Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumors
NCT01946529Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Dec 2013
- Primary completion
- Aug 2015
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus, temozolomide, irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab, bevacizumab, sorafenib in Ewing sarcoma, desmoplastic small round cell tumor (DSRCT), sponsored by St. Jude Children's Research Hospital. Started Dec 2013; status: completed.
02
Drugs
temsirolimustemozolomideirinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumabbevacizumabsorafenib
03
Conditions
Ewing sarcomadesmoplastic small round cell tumor (DSRCT)
Beyond the preview
Go deeper on NCT01946529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01946529.